Heterogeneity in Characteristics and Outcomes of Patients who met the Indications for Vericiguat Approved by the Japanese Agency: From the KCHF Registry.
J Card Fail
; 29(6): 976-978, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-37059291
Full text:
1
Database:
MEDLINE
Main subject:
Heart Failure
/
Heterocyclic Compounds, 2-Ring
Limits:
Humans
Language:
En
Journal:
J Card Fail
Journal subject:
CARDIOLOGIA
Year:
2023
Type:
Article
Affiliation country:
Japan